CRISPR Therapies, Rare Disease Drugs, and More
Kilder
- nature.com: Personalized CRISPR therapies could soon reach thousands — here’s how - Nature
- statnews.com: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a 'novel class' beyond it - statnews.com
- news.google.com: This Week’s Biopharma News: KRAS Breakthrough and ADC Momentum - The Medicine Maker
- news.google.com: At AACR, more strong results for Revolution Medicine's KRAS drug, plus assurance from NCI's director - statnews.com
- biospace.com: Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches - BioSpace
- bioworld.com: FDA grants priority review to Merck-Daiichi’s B7-H3 cancer ADC - BioWorld News
- fiercebiotech.com: With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines - Fierce Biotech
- biopharmadive.com: Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine - BioPharma Dive
- labiotech.eu: What new atopic dermatitis treatments are in the pipeline in 2026? - Labiotech.eu
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.